Literature DB >> 21239412

High-risk syndrome for neuromyelitis optica: a descriptive and comparative study.

N Collongues1, R Marignier, H Zéphir, F Blanc, S Vukusic, O Outteryck, M Fleury, A Ruet, F Borgel, E Thouvenot, T Moreau, G Defer, N Derache, J Pelletier, B Audoin, M Debouverie, P Labauge, O Gout, W Camu, D Brassat, B Brochet, P Vermersch, C Confavreux, J de Seze.   

Abstract

BACKGROUND: Neuromyelitis optica (NMO) frequently begins with a monofocal episode of optic neuritis or myelitis. A concept named high-risk syndrome (HRS) for NMO has been proposed for patients with monofocal episodes and NMO-IgG antibodies.
OBJECTIVE: To describe HRS patients and compare them with NMO patients.
METHODS: We identified 30 patients with HRS: 18 with extensive myelitis (HRM) and 12 with optic neuritis (HRON), in a database pooling patients from 25 centres in France. Clinical, laboratory/magnetic resonance imaging (MRI) data and outcome were analysed and compared with a national cohort of 125 NMO patients extracted from the same database.
RESULTS: Mean follow-up was 4.8 years. Mean age at onset was 42.8 years (range: 12.4-70) with a female:male ratio of 0.9. Asymptomatic lesions were report on visual evoked potentials in 4/8 tested HRM patients and on spinal cord MRI in 2/7 HRON patients. Three patients died, two owing to a cervical lesion. HRS and NMO patients had similar clinical/paraclinical data, except for a predominance of men in the HRS group and a later mean age at onset in the HRM subgroup.
CONCLUSION: The description of HRS patients is compatible with a monofocal form of NMO. Asymptomatic lesions could be included in a new set of NMO diagnostic criteria.

Entities:  

Mesh:

Year:  2011        PMID: 21239412     DOI: 10.1177/1352458510396923

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  3 in total

1.  Asymptomatic myelitis in neuromyelitis optica and autoimmune aquaporin-4 channelopathy.

Authors:  Eoin P Flanagan; Brian G Weinshenker; Karl N Krecke; Sean J Pittock
Journal:  Neurol Clin Pract       Date:  2015-04

Review 2.  A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course.

Authors:  Jacqueline M Solomon; Friedemann Paul; Claudia Chien; Jiwon Oh; Dalia L Rotstein
Journal:  Ther Adv Neurol Disord       Date:  2021-05-09       Impact factor: 6.570

3.  Recurrent Optic Neuritis as the Initial Symptom in Demyelinating Diseases.

Authors:  Alessandra Billi Falcão-Gonçalves; Denis Bernardi Bichuetti; Enedina Maria Lobato de Oliveira
Journal:  J Clin Neurol       Date:  2018-05-31       Impact factor: 3.077

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.